Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - cefepime, quantity: 1000 mg - injection, powder for - excipient ingredients: arginine - adults: cefepime is indicated in the treatment of the infections listed below when caused by susceptible bacteria.. - lower respiratory tract infections, including pneumonia and bronchitis. - urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. - skin and skin structure infections. intra-abdominal infections, including peritonitis and biliary tract infections. - gynaecological infections. septicaemia. - empirical treatment in febrile neutropenic patients (see precautions). cefepime is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. in this indication it is essential that metronidazole also be administered. paediatrics: cefepime is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria. pneumonia. - urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. - skin and skin structure infections. - septicaemia. - empirical treatment in febrile neutropenic patients (see precautions). culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. empirical therapy with cefepime may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly. because of its broad spectrum of bactericidal activity against gram positive and gram negative bacteria, cefepime can be used appropriately as monotherapy prior to identification of the causative organisms(s). in the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with cefepime. in patients who are at risk of mixed aerobic/ anaerobic infection, including infections in which bacterioides fragilis may be present, concurrent initial therapy with an antianaerobic agent is recommended before the causative organism(s) is known.

Namibia - English - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 500,0 mg

Namibia - English - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 1000,0 mg

Namibia - English - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 2000,0 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 2 g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

Malta - English - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - solution for injection/infusion - cefepime 1 g - antibacterials for systemic use

United States - English - NLM (National Library of Medicine)

cardinal health - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g

Singapore - English - HSA (Health Sciences Authority)

apex pharma marketing pte. ltd. - cefepime hydrochloride 1189 mg eqv cefepime base - injection, powder, lyophilized, for solution - 1000mg - cefepime hydrochloride 1189 mg eqv cefepime base 1000mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية الهلال - al hilal drug store - cefepime 1 gm - 1 gm